In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Sage W R GeherDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States.ORCID 0000-0002-7233-5593 Seyi FalekunDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States.ORCID 0000-0003-2280-4424 Jessica N Pita-AquinoDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States.ORCID 0000-0002-4333-214X Russell P SwiftDepartment of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States.ORCID 0000-0003-1442-9740 Megan OkadaDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States.ORCID 0000-0003-4398-9819 Sean T PriggeDepartment of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, United States.ORCID 0000-0001-9684-1733 Paul A SigalaDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States.ORCID 0000-0002-3464-3042 Funding
Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6MTraining Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0MDeterminants of apicoplast maintenance in malaria parasitesR01AI125534 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Sean Taylor PRIGGE · 2016 to 2026
$3.9MUnderstanding Ubiquitin-dependent Regulation of Iron Metabolism using Mass SpectrometryR35GM153408 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI James Akira Wohlschlegel · 2024 to 2026
$1.2MMolecular and Metabolic Adaptations of Intracellular ParasitismR35GM161383 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Paul A Sigala · 2026 to 2026
$462kNIAID NIH HHS R01 AI125534NIAID NIH HHS T32 AI055434NIDDK NIH HHS U54 DK110858NIGMS NIH HHS R35 GM153408NIGMS NIH HHS R35 GM161383
6 · The paper itselfAbstract
Acyl carrier protein (ACP) and its 4-phosphopantetheine prosthetic group canonically function as the soluble scaffold for acyl chain assembly and elongation during type-II fatty acid synthesis (FASII).
Identifiers
PMID41959251
PMCPMC13060071
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390